The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to severe acute pain.

Amycretin could give Novo a buzzy product in a newly competitive obesity market. It works similarly to existing GLP-1 ...

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some ...

One of the hottest growth areas in the healthcare landscape these days is the obesity drug market because of a class of drugs ...

Walgreens shares sank Tuesday, the first day of trading since the Department of Justice announced a lawsuit accusing the ...

Medicare released its next target list of 15 drugs to negotiate prices of, including Novo Nordisk's blockbuster GLP-1 drugs.

Johnson & Johnson ( JNJ) beat on fourth quarter and full-year 2024 results, but its stock traded down on Wednesday morning to ...

We recently compiled a list of the 15 Best Growth Stocks to Buy for the Next 5 Years. In this article, we are going to take a ...

We recently published a list of 10 AI Stocks Analysts Are Focusing On These Days. In this article, we are going to take a ...

Tempus AI, Inc. TEM recently unveiled olivia, an artificial intelligence (AI)-driven health concierge app designed to assist patients in managing their health. With olivia, users can centralize ...

In early 2023, Alex took a job at Cloud 9, a strip-mall smoke shop off Atlanta’s I-85. He had recently graduated from college ...

The U.S. Food and Drug Administration's decision to ban the ... A set of red drinks is seen in this undated stock photo. STOCK PHOTO/Getty Images When looking at food labels, in addition to ...